Immorta Bio reports 70% lifespan gain in preclinical study (opens in new tab)

New peer-reviewed findings suggest tackling two hallmarks of aging at once may outperform single-target approaches. Much of medicine has approached aging the same way it approaches disease – identify a problem, find a target and develop a treatment – but aging has never been that simple. Aging is not one process, one malfunction or one […] The post appeared first on <a href="